Pegasus Announces FFCTO Revocation Filings of Both Annual Financial Statements Plus First Quarter Results

Pegasus Mercantile Inc. (CSE: LOAN; OTC: XTCYF) announced that the British Columbia Securities Commission revoked a failure-to-file cease trade order effective March 2, 2026 after the company filed its audited annual financial statements, MD&A and CEO/CFO certificates for the year ended Sept. 30, 2025 on Feb. 27, 2026 and its first-quarter results for the period ending Dec. 31, 2025 on Mar. 2, 2026. Pegasus said it has requested the Canadian Securities Exchange lift the trading suspension and confirmed there are no changes to its business plan as it continues operations in wellness, psychedelics, mycology, hemp/CBD and healthcare-related targets.

Analysis

Market structure: Revocation of the FFCTO is a short-term positive for Pegasus (CSE: LOAN / OTC: XTCYF) because it permits trading resumption, but it does not change fundamentals immediately. Expect a supply shock: insiders and distressed holders often sell on day-of-resumption, so price pressure is most likely in the first 1–4 weeks; a 20–60% intraday move is plausible given typical microcap illiquidity. Cross-asset effects are negligible beyond small moves in psychedelics/hemp microcap peers and related ETFs (e.g., MJ) due to sentiment spillover.

Risk assessment: Tail risks include regulator re-instatement of FFCTO, auditor disagreement, discovery of undisclosed liabilities, or immediate dilutive financings; any such event could wipe out >80% of value for retail holders. Time horizons: immediate (days) = volatility/liquidity risk; short-term (weeks–months) = fundraising/dilution and management credibility; long-term (quarters–years) = execution on prospect-generator pipeline in psychedelics/hemp. Hidden dependencies: continued CSE acceptance, counterparty diligence on portfolio companies, and access to capital markets; catalysts are trading resumption confirmation, capital raises, and clinical-trial or M&A announcements.

Trade implications: Direct trade is a tightly sized, event-driven speculative long only after CSE confirms trading with at least two consecutive higher-volume days (use limit orders). If options on LOAN don’t exist, express sector hedge via short position in MJ (ETFMG Alternative Harvest ETF) or buy 3–6 month put spreads on MJ to protect against a sentiment-driven sell-off. Entry: post-resumption with confirmed volume; exit/stop: hard stop at −35% or cut if new regulatory action within 30 days; target take-profit scaling at +100% and +200% over 6–12 months.

Contrarian angle: The market usually over-penalizes clean filers after an FFCTO; if filings are audited and disclosures are clear, a meaningful mispricing window can last 3–9 months allowing outsized returns for disciplined, small-sized entries. Consensus underestimates dilution risk — assume a subsequent capital raise with 10–30% immediate share increase if cash runway is short; historical parallels (microcap restatements/FFCTO revocations) often see 30–70% drawdowns followed by recoveries only if management proves funding and deal flow within 6–12 months. Unintended consequence: low secondary market liquidity may prevent viable exits — plan position sizing accordingly.

Key Decisions for Investors

• Establish a tactical 2–3% long position in Pegasus Mercantile (CSE: LOAN / OTC: XTCYF) only after the Canadian Securities Exchange confirms trading resumption and there are two consecutive trading days with volume >5,000 shares; use a hard stop-loss at −35% and scale out 50% at +100% and the remainder at +200%; horizon 6–12 months.
• Hedge sector/sentiment risk by shorting MJ (ETFMG Alternative Harvest ETF) equal to 0.5–1.0% of portfolio notional or buy a 3–6 month MJ put spread (sell nearer-dated put to offset premium) sized to cover ~50% of the LOAN position’s dollar risk.
• If direct options on LOAN are unavailable, buy 3-month protective puts on any purchased LOAN equity where liquid, or pre-fund a limit sell order to enforce the −35% stop; if there is evidence of imminent fundraising (press release or SEDAR filing within 30 days), reduce position to 0.5% immediately.
• Reduce aggregated exposure to illiquid psychedelics/hemp microcaps by 15–25% over the next 30 days and reallocate that capital into liquid sector hedges (e.g., defensive biotech/healthcare ETFs or cash) until Pegasus demonstrates concrete funding or pipeline milestones within 90 days.